Tandem Diabetes Care, Inc. (LON:0M0F)
16.00
-0.05 (-0.31%)
At close: Jul 11, 2025
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,650 employees as of December 31, 2024. The number of employees increased by 250 or 10.42% compared to the previous year.
Employees
2,650
Change (1Y)
250
Growth (1Y)
10.42%
Revenue / Employee
287.09K GBP
Profits / Employee
-53.70K GBP
Market Cap
769.27M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,650 | 250 | 10.42% |
Dec 31, 2023 | 2,400 | -200 | -7.69% |
Dec 31, 2022 | 2,600 | 600 | 30.00% |
Dec 31, 2021 | 2,000 | 500 | 33.33% |
Dec 31, 2020 | 1,500 | 457 | 43.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
British American Tobacco p.l.c. | 48,989 |
Rolls-Royce Holdings | 42,400 |
Rio Tinto Group | 60,000 |
RELX PLC | 36,400 |